automatic peptide synthesizer syro i (BIOTAGE)
90
Structured Review
BIOTAGE
automatic peptide synthesizer syro i
Automatic Peptide Synthesizer Syro I, supplied by BIOTAGE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/syro-i/syro+i+peptide+synthesizer/pmc09996831__bi2c00656_si_001-124-10-14
Average 90 stars, based on 1 article reviews
Automatic Peptide Synthesizer Syro I, supplied by BIOTAGE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/syro-i/syro+i+peptide+synthesizer/pmc09996831__bi2c00656_si_001-124-10-14
Average 90 stars, based on 1 article reviews
automatic peptide synthesizer syro i - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Purification:Article Title: Manipulating Active Structure and Function of Cationic Antimicrobial Peptide CM15 with the Polysulfonated Drug Suramin: A Step Closer to in Vivo Complexity Article Snippet: Article Title: Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing Article Snippet: Peptide L1 was synthesized on Article Title: Enhanced cellular uptake of a new, in silico identified antitubercular candidate by peptide conjugation. Article Snippet: Mycobacterium tuberculosis is a successful pathogen, and it can survive in infected macrophages in dormant phase for years and decades.. The therapy of tuberculosis takes at least six months, and the slow-growing bacterium is resistant to many antibiotics.. The development of novel antimicrobials to counter the emergence of bacteria resistant to current therapies is urgently needed. Article Title: Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing Article Snippet: Peptide L1 was synthesized on Article Title: A Convenient Synthetic Method to Improve Immunogenicity of Mycobacterium tuberculosis Related T-Cell Epitope Peptides Article Snippet: Peptides were produced on solid phase (Fmoc-Rink Amide MBHA resin, capacity = 0.67 mmol/g) in an automated Article Title: Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides Article Snippet: Peptides were produced on solid phase (Fmoc-Rink Amide MBHA resin, capacity = 0.67 mmol/g), in an automated Produced:Article Title: Manipulating Active Structure and Function of Cationic Antimicrobial Peptide CM15 with the Polysulfonated Drug Suramin: A Step Closer to in Vivo Complexity Article Snippet: Article Title: Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing Article Snippet: Peptide L1 was synthesized on Article Title: Enhanced cellular uptake of a new, in silico identified antitubercular candidate by peptide conjugation. Article Snippet: Mycobacterium tuberculosis is a successful pathogen, and it can survive in infected macrophages in dormant phase for years and decades.. The therapy of tuberculosis takes at least six months, and the slow-growing bacterium is resistant to many antibiotics.. The development of novel antimicrobials to counter the emergence of bacteria resistant to current therapies is urgently needed. Article Title: Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing Article Snippet: Peptide L1 was synthesized on Article Title: A Convenient Synthetic Method to Improve Immunogenicity of Mycobacterium tuberculosis Related T-Cell Epitope Peptides Article Snippet: Peptides were produced on solid phase (Fmoc-Rink Amide MBHA resin, capacity = 0.67 mmol/g) in an automated Article Title: Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides Article Snippet: Peptides were produced on solid phase (Fmoc-Rink Amide MBHA resin, capacity = 0.67 mmol/g), in an automated Sequencing:Article Title: Manipulating Active Structure and Function of Cationic Antimicrobial Peptide CM15 with the Polysulfonated Drug Suramin: A Step Closer to in Vivo Complexity Article Snippet: Article Title: Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing Article Snippet: Peptide L1 was synthesized on Article Title: Enhanced cellular uptake of a new, in silico identified antitubercular candidate by peptide conjugation. Article Snippet: Mycobacterium tuberculosis is a successful pathogen, and it can survive in infected macrophages in dormant phase for years and decades.. The therapy of tuberculosis takes at least six months, and the slow-growing bacterium is resistant to many antibiotics.. The development of novel antimicrobials to counter the emergence of bacteria resistant to current therapies is urgently needed. Article Title: Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing Article Snippet: Peptide L1 was synthesized on Article Title: A Convenient Synthetic Method to Improve Immunogenicity of Mycobacterium tuberculosis Related T-Cell Epitope Peptides Article Snippet: Peptides were produced on solid phase (Fmoc-Rink Amide MBHA resin, capacity = 0.67 mmol/g) in an automated Article Title: Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides Article Snippet: Peptides were produced on solid phase (Fmoc-Rink Amide MBHA resin, capacity = 0.67 mmol/g), in an automated |